Roberta Duncan

Roberta Duncan, MBA, currently serves as Chief Strategy Officer at Arcturus Therapeutics and holds the position of Strategic Advisor on the Intelisci Scientific Advisory Board. Additionally, Roberta is the Vice Chair of the Alliance for mRNA Medicines Board and the President and Founder of Strategic Clinical Research Consulting, LLC. Previous experience includes roles as VP of the mRNA Program and Head of PPM-BOSS and BOSS-CC at CSL Seqirus. Roberta is pursuing an MBA in International Management from Purdue University Daniels School of Business and TIAS School for Business and Society, both since 2011.